Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Yousefi, Hassan  [Clear All Filters]
2023
Torabian P, Yousefi H, Fallah A, Moradi Z, Naderi T, Delavar MRostamian, Ertas YNuri, Zarrabi A, Aref AReza. Cancer stem cell-mediated drug resistance: A comprehensive gene expression profile analysis in breast cancer. Pathol Res Pract. 2023;246:154482.
Dong S, Matossian MD, Yousefi H, Khosla M, Collins-Burow BM, Burow ME, Alahari SK. Targeting Mcl-1 by a small molecule NSC260594 for triple-negative breast cancer therapy. Sci Rep. 2023;13(1):11843.
2021
Momeny M, Shamsaiegahkani S, Kashani B, Hamzehlou S, Esmaeili F, Yousefi H, Irani S, Mousavi SA, Ghaffari SH. Cediranib, a pan-inhibitor of vascular endothelial growth factor receptors, inhibits proliferation and enhances therapeutic sensitivity in glioblastoma cells. Life Sci. 2021:120100.
2020
Afrough H, Ghafouri-Fard S, Yousefi H, Pakzad P, Oskooei VKholghi, Taheri M. DICER-AS1 lncRNA: A putative culprit in the pathogenesis of gastric cancer. Exp Mol Pathol. 2020:104490.
2019
Hamzehlou S, Momeny M, Zandi Z, Kashani B, Yousefi H, Dehpour AR, Tavakkoly-Bazzaz J, Ghaffari SH. Anti-tumor activity of neratinib, a pan-HER inhibitor, in gastric adenocarcinoma cells. Eur J Pharmacol. 2019:172705.
Vatanmakanian M, Yousefi H, Mashouri L, Aref AReza, Khamisipour G, Bitaraf A, Alizadeh S. Generation of Induced Pluripotent Cancer Cells from Glioblastoma Multiform Cell Lines. Cell Reprogram. 2019.